Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aaron Coinneach Author

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker

Affiliation
Department of Surgery, University of Calabar, Calabar, Nigeria

Biography

Aaron Coinneach was working in the Department of Surgery, University of Calabar, Calabar, Nigeria. Doctor has more than 40 publications. Doctor's current research area related to clinical oncology.


Publications

Editorial Open Access

Arimidex is a kind of chemical treatment called an aromatase inhibitor

Author(s):

Aaron Coinneach

Arimidex (compound name: anastrozole) is an aromatase inhibitor endorsed by the U.S. Food and Drug Administration (FDA) to treat: postmenopausal ladies determined to have chemical receptor-positive, beginning phase bosom malignancy after medical procedure (or conceivably chemotherapy and radiation) to lessen the danger of the disease returning These medications work by preventing the chemical estrogen from urging malignant growth cells to develop and spread. Arimidex is a kind of chemical treatment called an aromatase inhibitor. It works by preventing estrogen from being made in your body by the aromatase protein. Weight gain may likewise happen on the grounds that aromatase inhibitors, (for example, anastrozole) neutralize the impacts of estrogen.

... view moreĀ»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP